Company · Ownership research

Pacira BioSciences, Inc. PCRX

CIK 0001396814

Form 4 transactions dated Nov 1, 2023 to Nov 7, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 44 rows; the complete set is available through the API.

Insider filings on file run through Nov 3, 2026.

Insider purchases & sales

Purchased: $215.68K
Sold: $7.76M

Nov 1, 2023 – Nov 3, 2026
Available records · partial months are marked ·

202610 of 13 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Oct 8, 2026	RIKER LAUREN Senior Vice President, Finance	Sale10b5-1 footnote	$217.92K 6,000 shares sold	8.79% sold Direct holding	▾
Aug 17, 2026	SLONIN JONATHAN Chief Medical Officer	Sale10b5-1 footnote	$70.62K 3,040 shares sold	1.39% sold Direct holding	▾
Jun 11, 2026	RIKER LAUREN Senior Vice President, Finance	Sale10b5-1 footnote	$143.70K 6,115 shares sold	8.94% sold Direct holding	▾
Jun 4, 2026	WILLIAMS KRISTEN Chief Administrative Officer	Sale10b5-1 footnote	$228.47K 10,259 shares sold	5.79% sold Direct holding	▾
Apr 23, 2026	Cross Shawn Chief Financial Officer	Sale10b5-1 footnote	$325.60K 12,941 shares sold	10.94% sold Direct holding	▾
Apr 22, 2026	Cross Shawn Chief Financial Officer	Sale10b5-1 footnote	$37.52K 1,500 shares sold	1.40% sold Direct holding	▾
Apr 21, 2026	Cross Shawn Chief Financial Officer	Sale10b5-1 footnote	$71.15K 2,845 shares sold	2.63% sold Direct holding	▾
Apr 20, 2026	Cross Shawn Chief Financial Officer	Sale10b5-1 footnote	$193.93K 7,714 shares sold	6.82% sold Direct holding	▾
Mar 17, 2026	SLONIN JONATHAN Chief Medical Officer	Sale10b5-1 footnote	$74.42K 3,261 shares sold	1.44% sold Direct holding	▾
Mar 17, 2026	Froimson Mark Director	Sale	$10.90K 500 shares sold	2.42% sold Direct holding	▾

Showing 13 / 13 record groups in 2026. The complete set is available through the API.

Pacira BioSciences, Inc. · PCRX

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 13 of 13 purchase / sale groups and 30 of 44 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"PCRX","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.